about
Obstructive sleep apnea, atrial fibrillation, and erectile dysfunction: are they only coexisting conditions or a new clinical syndrome? The concept of the OSAFED syndromeAssessment of CHADS2 and CHA 2DS 2-VASc scores in obstructive sleep apnea patients with atrial fibrillation.Association of the CHADS2 and CHA 2DS 2-VASc scores with left atrial enlargement: a prospective cohort study of unselected atrial fibrillation patients.Presence and severity of obstructive sleep apnea and remote outcomes of atrial fibrillation ablations - a long-term prospective, cross-sectional cohort study.OSACS score-a new simple tool for identifying high risk for Obstructive Sleep Apnea Syndrome based on clinical parameters.Stroke Risk Factors Beyond the CHA₂DS₂-VASc Score: Can We Improve Our Identification of "High Stroke Risk" Patients With Atrial Fibrillation?Peripehral ARtery Atherosclerotic DIsease and SlEep disordered breathing (PARADISE) trial - protocol for an observational cohort study.Prevalence of depressive disorders in professional drivers - epidemiologic subanalysis of the RACER study.Differences of psychological features in patients with heart failure with regard to gender and aetiology - Results of a CAPS-LOCK-HF (Complex Assessment of Psychological Status Located in Heart Failure) study.Assessment of cardiovascular risk in patients undergoing total joint alloplasty: the CRASH-JOINT study.Prevalence of Erectile Dysfunction in Atrial Fibrillation Patients: A Cross-Sectional, Epidemiological Study.A study to evaluate the prevalence and determinants of stress coping strategies in heart failure patients in Poland (CAPS-LOCK-HF sub-study).Usefulness of the SAME-TT2R2 score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea.Stratification of cardiovascular risk in patients with atrial fibrillation and obstructive sleep apnea-validity of the 2MACE score.Myocardial infarction type 4b in human immunodeficiency virus-infected patient.Obstructive sleep apnoea in patients with atrial fibrillation: prevalence, determinants and clinical characteristics of patients in Polish population.Long QT interval in a patient after out-of-hospital cardiac arrest with hypocalcaemia, undergoing therapeutic hypothermia.[Should cardiologist routinely screen and evaluate patients for sleep disordered breathing?].The prevalence of sexual dysfunction before myocardial infarction in population of Polish men: a retrospective pilot study.Usefulness of the D-dimer concentration as a predictor of mortality in patients with out-of-hospital cardiac arrest.Does time delay between the primary cardiac arrest and PCI affect outcome?Seasonal trends in hypertension in Poland: evidence from Google search engine query data.Negative predictors of treatment success in outpatient therapy of arterial hypertension in Poland. Results of the CONTROL NT observational registry.Risk assessment according to the SCORE risk chart - from history, through present, to the future.Which components of the CHA2DS2-VASc score are the most important in obstructive sleep apnea patients with atrial fibrillation?Can continuous positive airway pressure therapy have antiarrhythmic properties?Sleep apnea and atrial fibrillation in coronary artery bypass grafting patients--also a part of the OSAFED syndrome?Is obstructive sleep apnea associated with the risk of ischemic stroke in patients with atrial fibrillation?Occurrence of poor sleep quality in atrial fibrillation patients according to the EHRA score.Perception of health control and self-efficacy in heart failure.Sleep duration in the first months after ST elevation myocardial infarction: an independent predictor of all-cause mortality.Prognostic value of troponin I and NT-proBNP concentrations in patients after in-hospital cardiac arrest.The high risk of obstructive sleep apnea--an independent risk factor of erectile dysfunction in ST-segment elevation myocardial infarction patients.Evaluation of the prevalence of periodontal disease, as a non-classical risk factor in the group of patients undergoing hip and/or knee arthroplasty.Epidemiology of dyslipidemia in professional drivers - results of RACER-ABPM (Risk of Adverse Cardiovascular Events among professional dRivers in Poland - Ambulatory Blood Pressure Monitoring) study.The use of an automated external defibrillator in a victim of car accident.Comparison of hypertension epidemiology and treatment in Poland and Australia.Utilization of the lipid-lowering therapies in outpatient settings in Poland - epidemiological survey Economedica Dyslipidemia 2015.Prevalence of Hypertension in Professional Drivers (from the RACER-ABPM Study).Bioequivalence study of 2.5 mg film-coated bisoprolol tablets in healthy volunteers.
P50
Q27011674-C75E2A21-DDB3-4289-9134-716331EDFD5EQ35597696-4B9D6C39-9606-4383-A732-870FDF0F95C5Q35768680-3F87F10A-7385-4C68-9DF3-5D1C16AFE809Q36024079-26D325EB-A917-4CB3-83FE-994E30CF1609Q37680488-9089F440-AEF7-485C-A3EB-ED007FA3288DQ38598690-BD512BE9-7BB0-4418-B9FF-D1FBA0572735Q38675827-F1167B35-357F-45D0-B8D4-B82F2B1F5872Q39185030-FD82A310-680F-482F-BF97-04E9ED566B7CQ39645622-26B01D31-AC2A-4CAF-B272-A3D90F6364B4Q40460912-6C533C69-0DC6-44D8-BDF0-2E7EFC171FC7Q40493899-DDE293E3-24A2-4540-AF4F-9454B0ADD9D3Q40661347-E8BF4BA6-5DAE-49EB-8FE3-1D6D9F0237B6Q41048561-F8657028-12C8-4B04-BADE-C7001A66551CQ41620649-245D6DD7-B51A-4154-BA37-944ECBBABD15Q41896951-8E6814BE-6056-4C98-9247-F5850BC682E4Q43446634-90F76250-3F52-4D1F-9A0E-1D0EA139B7C3Q43454044-831F9F92-CC07-4CA5-A9A6-D9D41076D304Q43677392-7B8FA7C6-97BF-48E2-8440-0D8CE400FA3BQ43898247-FE1673E5-D43F-4BCB-B00C-36E4506E573BQ44553766-2E717D07-3175-42FE-9714-6D692BE2B29FQ46353239-A6CF9467-8FE5-4CCC-B34C-AF814CEA199EQ47203230-1EE9CE10-A3B6-473D-AFAA-FF818064913BQ47608601-D5FE9FF3-06A2-4147-BD39-132FD339FCCBQ47843324-5E52F1AA-77FA-420B-B227-5B59A265C8A2Q47873164-8E1F106A-63CC-47AC-A7B2-3E9E9D360EDCQ47943893-737F1A14-E56E-4478-AE0E-60B9999CC8E4Q47944815-51774BCE-7DA3-495F-BFE2-48231391C99CQ47989054-0A15B106-09EE-4D60-B6B6-83D7DFB40EAEQ48070702-7E8A4A56-585F-4035-9C16-118D411BEC09Q48077699-977CF424-9282-40BD-AE06-DDD4EC88C915Q48125841-CF2F2214-A0B3-4647-A3D3-AF37CF0A21FCQ48247882-CE2CDF36-ED7B-4C79-BF4E-71C501A7B4A0Q48336297-4235C603-1DA4-42F0-86C1-1D6D07278767Q49350051-5A6B0DD7-A321-4511-B15F-85E7323EBF26Q49382975-BE186A82-57D8-47C2-8863-81CD8BE912B1Q50048711-D84C6015-6294-4A7F-81BA-FB00B35036AEQ50126698-F98F7675-FBE5-4CEB-9131-9500AD16018DQ50126705-21405D07-1E18-4942-B24F-A77B17CB3306Q50195912-52D03619-DE48-48C0-91E3-EA5290353ED1Q50879003-A7BA5F96-61A5-49DC-9209-D331EA249C06
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-2638-7894
@en
name
Filip M Szymanski
@ast
Filip M Szymanski
@en
Filip M Szymanski
@es
Filip M Szymanski
@nl
type
label
Filip M Szymanski
@ast
Filip M Szymanski
@en
Filip M Szymanski
@es
Filip M Szymanski
@nl
prefLabel
Filip M Szymanski
@ast
Filip M Szymanski
@en
Filip M Szymanski
@es
Filip M Szymanski
@nl
P106
P1153
13907301300
P31
P496
0000-0002-2638-7894